Published in Physician Law Weekly, September 8th, 2004
EP-2104R binds selectively to fibrin, an important component of thrombus, and is designed to provide a bright MR image to allow the detection of small clots in arteries and veins, many of which may be undetectable with currently available imaging methods. Early thrombus detection may enable better therapeutic decision-making for patients with cardiovascular disease. The trial will be conducted in the U.S. under a U.S....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.